| Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B2 and M1 muscarinic acetylcholine receptors KLP Morais, MAF Hayashi, FM Bruni, M Lopes-Ferreira, ACM Camargo, ... Biochemical pharmacology 81 (6), 736-742, 2011 | 48 | 2011 |
| Interactions between the NO-citrulline cycle and brain-derived neurotrophic factor in differentiation of neural stem cells C Lameu, CA Trujillo, TT Schwindt, PD Negraes, MM Pillat, KLP Morais, ... Journal of Biological Chemistry 287 (35), 29690-29701, 2012 | 45 | 2012 |
| Proline rich-oligopeptides: Diverse mechanisms for antihypertensive action KLP Morais, D Ianzer, JRR Miranda, RL Melo, JR Guerreiro, RAS Santos, ... Peptides 48, 124-133, 2013 | 44 | 2013 |
| A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production DA Maria, JG de Souza, KLP Morais, CM Berra, HC Zampolli, M Demasi, ... Investigational new drugs 31, 493-505, 2013 | 40 | 2013 |
| The central nervous system as target for antihypertensive actions of a proline‐rich peptide from Bothrops jararaca venom C Lameu, MAF Hayashi, JR Guerreiro, EF Oliveira, I Lebrun, V Pontieri, ... Cytometry Part A: The Journal of the International Society for Advancement …, 2010 | 33 | 2010 |
| Tick salivary gland as potential natural source for the discovery of promising antitumor drug candidates AM Chudzinski-Tavassi, KLP Morais, MTF Pacheco, KFM Pasqualoto, ... Biomedicine & Pharmacotherapy 77, 14-19, 2016 | 29 | 2016 |
| A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis … LC Castellucci, L Almeida, S Cherlin, M Fakiola, RW Francis, ... Clinical Infectious Diseases 72 (10), e515-e525, 2021 | 23 | 2021 |
| Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model JG de Souza, KLP Morais, E Anglés-Cano, P Boufleur, ES de Mello, ... Oncotarget 7 (38), 62255, 2016 | 22 | 2016 |
| A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis JS Ventura, F Faria, IFC Batista, SM Simons, DGL Oliveira, KLP Morais, ... Biomedicine & Pharmacotherapy 67 (3), 192-196, 2013 | 22 | 2013 |
| Amblyomin-X induces ER stress, mitochondrial dysfunction, and caspase activation in human melanoma and pancreatic tumor cell KLP Morais, MTF Pacheco, CM Berra, RV Bosch, JM Sciani, R Chammas, ... Molecular and Cellular Biochemistry 415, 119-131, 2016 | 21 | 2016 |
| Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-X MTF Pacheco, CM Berra, KLP Morais, JM Sciani, VG Branco, RV Bosch, ... PloS one 9 (12), e111907, 2014 | 20 | 2014 |
| Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells MCB Schmidt, KLP Morais, MES Almeida, A Iqbal, MB Goldfeder, ... Cell Adhesion & Migration 14 (1), 129-138, 2020 | 14 | 2020 |
| Comprometimento organizacional e qualidade de vida no trabalho de pessoas com deficiência: um estudo no setor bancário AL Marques, MN Carvalho-Freitas, K Morais, LAD Almeida Anais do Encontro da Anpad, 2010 | 14 | 2010 |
| Specific role of cytoplasmic dynein in the mechanism of action of an antitumor molecule, Amblyomin-X MTF Pacheco, KLP Morais, CM Berra, M Demasi, JM Sciani, VG Branco, ... Experimental Cell Research 340 (2), 248-258, 2016 | 13 | 2016 |
| A Lipocalin‐Derived Peptide Modulating Fibroblasts and Extracellular Matrix Proteins LC Carrijo-Carvalho, DA Maria, JS Ventura, KLP Morais, RL Melo, ... Journal of Toxicology 2012 (1), 325250, 2012 | 12 | 2012 |
| Bothrops jararaca Peptide with Anti-Hypertensive Action Normalizes Endothelium Dysfunction Involved in Physiopathology of Preeclampsia G Benedetti, KLP Morais, JR Guerreiro, EF Oliveira, MS Hoshida, ... PloS one 6 (8), e23680, 2011 | 12 | 2011 |
| Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model F Lichtenstein, A Iqbal, SEA de Lima Will, RV Bosch, ... Scientific reports 10 (1), 6388, 2020 | 11 | 2020 |
| Zampolli Hde C, Demasi M, Simons SM, de Freitas SR, Chammas R, Chudzinski-Tavassi AM: A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production DA Maria, JG de Souza, KL Morais, CM Berra Invest New Drugs 31, 493-505, 2013 | 8 | 2013 |
| Human Chondrocyte Activation by Toxins From Premolis semirufa, an Amazon Rainforest Moth Caterpillar: Identifying an Osteoarthritis Signature IM Villas-Boas, G Pidde, F Lichtenstein, ATC Ching, ... Frontiers in Immunology 11, 2191, 2020 | 7 | 2020 |
| Rational development of a novel TFPI-like inhibitor from Amblyomma cajennense tick KLP Morais, KFM Pasqualoto, MTF Pacheco, CM Berra, ... Toxin Reviews 33 (1-2), 48-52, 2014 | 5 | 2014 |
